DE69521378T2 - Cephemderivat, verfahren zu dessen herstellung und dieses enthaltendes antibakterielles mittel - Google Patents

Cephemderivat, verfahren zu dessen herstellung und dieses enthaltendes antibakterielles mittel

Info

Publication number
DE69521378T2
DE69521378T2 DE69521378T DE69521378T DE69521378T2 DE 69521378 T2 DE69521378 T2 DE 69521378T2 DE 69521378 T DE69521378 T DE 69521378T DE 69521378 T DE69521378 T DE 69521378T DE 69521378 T2 DE69521378 T2 DE 69521378T2
Authority
DE
Germany
Prior art keywords
production
antibacterial agent
agent containing
cephem derivative
cephem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69521378T
Other languages
English (en)
Other versions
DE69521378D1 (de
Inventor
Hiroshi Akagi
Masaru Yasui
Takae Yamada
Masahiro Ito
Hideaki Hanaki
Akio Hyodo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Chemical Co Ltd
Taiho Pharmaceutical Co Ltd
Original Assignee
Otsuka Chemical Co Ltd
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Chemical Co Ltd, Taiho Pharmaceutical Co Ltd filed Critical Otsuka Chemical Co Ltd
Application granted granted Critical
Publication of DE69521378D1 publication Critical patent/DE69521378D1/de
Publication of DE69521378T2 publication Critical patent/DE69521378T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69521378T 1994-03-17 1995-03-17 Cephemderivat, verfahren zu dessen herstellung und dieses enthaltendes antibakterielles mittel Expired - Fee Related DE69521378T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4673794 1994-03-17
PCT/JP1995/000471 WO1995025109A1 (fr) 1994-03-17 1995-03-17 Compose de cephem, procede d'obtention de ce compose et agent antibacterien contenant celui-ci

Publications (2)

Publication Number Publication Date
DE69521378D1 DE69521378D1 (de) 2001-07-26
DE69521378T2 true DE69521378T2 (de) 2002-05-29

Family

ID=12755650

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69521378T Expired - Fee Related DE69521378T2 (de) 1994-03-17 1995-03-17 Cephemderivat, verfahren zu dessen herstellung und dieses enthaltendes antibakterielles mittel

Country Status (6)

Country Link
US (1) US5698544A (de)
EP (1) EP0700916B1 (de)
KR (1) KR100358312B1 (de)
CA (1) CA2163080C (de)
DE (1) DE69521378T2 (de)
WO (1) WO1995025109A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996038451A1 (en) * 1995-05-29 1996-12-05 Takeda Chemical Industries, Ltd. Cephem compounds, their production and use
DK0949262T3 (da) * 1996-12-25 2001-12-17 Zenyaku Kogyo Kk Cephemforbindelser
US6265394B1 (en) 1997-07-31 2001-07-24 Bristol-Myers Squibb Company Bis quaternary MRSA cephem derivatives
US7182434B2 (en) 1999-06-30 2007-02-27 Silverbrook Research Pty Ltd Inkjet printhead assembly having aligned printhead segments
KR100453713B1 (ko) * 2002-02-28 2004-10-20 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조 방법
US20050100637A1 (en) 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79043B (de) * 1982-12-06 1984-10-02 Fujisawa Pharmaceutical Co
US5484928A (en) * 1984-04-10 1996-01-16 Biochemie Gesellschaft M.B.H. 2-(2-aminothiazol-4-yl)-2-oxoacetic acid derivatives
US4761410A (en) * 1985-01-14 1988-08-02 Fujisawa Pharmaceutical Co., Ltd. Cephem Compounds
GB8504072D0 (en) * 1985-02-18 1985-03-20 Fujisawa Pharmaceutical Co Cephem compounds
US5403835A (en) * 1986-03-20 1995-04-04 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives
WO1994006804A1 (en) * 1992-09-18 1994-03-31 Otsuka Kagaku Kabushiki Kaisha Cephem compound, process for producing the same, and medicine containing the same
CN1150429A (zh) * 1994-05-23 1997-05-21 韩国科学技术研究院 头孢菌素化合物及其制备方法

Also Published As

Publication number Publication date
KR960702467A (ko) 1996-04-27
EP0700916B1 (de) 2001-06-20
KR100358312B1 (ko) 2005-09-30
US5698544A (en) 1997-12-16
EP0700916A4 (de) 1996-07-24
EP0700916A1 (de) 1996-03-13
WO1995025109A1 (fr) 1995-09-21
DE69521378D1 (de) 2001-07-26
CA2163080C (en) 2003-07-15
CA2163080A1 (en) 1995-09-21

Similar Documents

Publication Publication Date Title
ATE379971T1 (de) Disinfektionsmittel und verfahren zu dessen herstellung
DE69524928D1 (de) Wasser-absorbent, verfahren zu dessen herstellung und den enthaltender absorbent-gegenstand
DE69410470D1 (de) Modifiziertes konjugiertes diencopolymer, verfahren zu dessen herstellung und zusammensetzung daraus
DE69532895D1 (de) Biomaterial und verfahren zu dessen herstellung
DE69527370D1 (de) Chitosan-salze und verfahren zu deren herstellung
DE69733416D1 (de) Erythromycine und verfahren zu ihrer herstellung
DE69526443D1 (de) 2-silyloxy-tetrahydrothienopyridin, sein salz und verfahren zu seiner herstellung
DE69730404D1 (de) Luftreifen und verfahren zu dessen herstellung
DE69503332T2 (de) Gleitstück und verfahren zu dessen herstellung
ATE206118T1 (de) Indolyl-pyrrolylidenmethylpyrrol-derivate und verfahren zu ihrer herstellung
DE69634530D1 (de) Antivirales mittel und verfahren zu dessen herstellung
DE69813008D1 (de) Luftreifen und verfahren zu dessen herstellung
DE69523571D1 (de) Pyridylimidazol-derivate und verfahren zu ihrer herstellung
DE69521378D1 (de) Cephemderivat, verfahren zu dessen herstellung und dieses enthaltendes antibakterielles mittel
DE69518647T2 (de) Pyridyl-imidazol-derivate und verfahren zu ihrer herstellung
DE69735099D1 (de) Antibiotika rk-1061 und verfahren zu ihrer herstellung
DE69527445T2 (de) Aminooligosaccharid-derivate und verfahren zu ihrer herstellung
DE69421182D1 (de) Neue clathrat-verbindungen, verfahren zu ihrer herstellung und fäulmisverhinderndes mittel
DE69331047D1 (de) 2-isocephem und -oxacephemderivate,verfahren zu deren herstellung, deren zwischenprodukte und verwendung als antibakterielle mittel
DE69712361D1 (de) Erythromycinderivate, verfahren zu ihrer herstellung, und ihrer verwendung als arzneimitteln
DE69723266D1 (de) Wässrige verdickerzusammensetzung und verfahren zu ihrer herstellung
DE69625174D1 (de) Gleitteil und verfahren zu dessen herstellung
ATA51598A (de) Antibakterielle 7-acylamino-3-iminomethyl- cephalosporine und verfahren zu deren herstellung
DE69515341D1 (de) Diarylethylen-metallogenderivate, verfahren zu deren herstellung und diese enthaltende arzneizusammensetzungen
DE69932578D1 (de) Trifluoro-methylthiomethyl-benzolderivate und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee